SPECTRUM PHARMACEUTICALS INC Annual Nonoperating Income (Expense) in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2022.
  • Spectrum Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$136K, a 89.7% increase year-over-year.
  • Spectrum Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$4.17M, a 58.5% increase year-over-year.
  • Spectrum Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was -$5.36M, a 50% increase from 2021.
  • Spectrum Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was -$10.7M, a 571% decline from 2020.
  • Spectrum Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2020 was -$1.6M, a 59% increase from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$5.36M +$5.37M +50% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 -$10.7M -$9.13M -571% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$1.6M +$2.3M +59% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 -$3.9M -$13.1M -142% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $9.24M +$15.6M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
2017 -$6.41M +$2.79M +30.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$9.2M +$450K +4.67% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$9.65M +$2.32M +19.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 -$12M -$14.1M -657% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
2013 $2.15M +$2.99M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$844K +$2.07M +71% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 -$2.91M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.